Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line

J Clin Oncol. 2005 Dec 20;23(36):9441-2. doi: 10.1200/JCO.2005.04.4792.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Clinical Trials as Topic
  • Colorectal Neoplasms / drug therapy*
  • Drug Administration Schedule
  • Fluorouracil / administration & dosage
  • Health Services Accessibility
  • Humans
  • Irinotecan
  • Models, Theoretical
  • Organoplatinum Compounds / administration & dosage
  • Oxaliplatin
  • Survival Analysis

Substances

  • Organoplatinum Compounds
  • Oxaliplatin
  • Irinotecan
  • Fluorouracil
  • Camptothecin